Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan

Breast Cancer Research and Treatment

Volumn 90, Issue 3, 2005, Pages 257-261

  Chang, Nai Wen ^a   Chen, Dar Ren ^b   Wu, Chen Ten ^c   Aouizerat, Bradley E ^d   Chen, Fei Na ^e   Hung, Shin Jer ^f   Wang, Shiuan Huei ^g   Wei, Ming Feng ^a   Chang, Cheng Shyong ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c FENG YUAN HOSPITAL   (Taiwan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g Chinese Blood Services Foundation   (Taiwan)

Author keywords

Apolipoprotein E polymorphism; Breast cancer; HER2 neu

Indexed keywords

APOLIPOPROTEIN E; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN;

ADULT; AGED; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LIPID METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RISK FACTORS; TAIWAN;

EID: 17744379364     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-4656-7     Document Type: Article

References (26)

1. RW Mahley 1998 Apolipoprotein E cholesterol transport protein with expanding role in cell biology Science 240 622 630
2. J Davignon RE Gregg CF Siing 1988 Apolipoprotein E polymorphism and atherosclerosis Atherosclerosis 8 1 21
3. J Poirer J Davignon D Bouthillier 1993 Apolipoprotein E polymorphism and Alzheimer's disease Lancet 342 697 699
4. JL Breslow 1989 Genetic basis of lipoprotein disorders J Clin Invest 84 373 380
5. G Uterman 1987 Apolipoprotein E polymorphism in health and disease Am Heart J 113 433 440
6. EH Corder AM Saunders WJ Strittmatter A Roses 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 921 923
7. AM Saunders WJ Strittmatter D Schmechel A Roses 1993 Association of apolipoprotein ε4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1467 1472
8. WJ Strittmatter AM Saunders D Schmechel A Roses 1993 Apolipoprotein E: high-activity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease Proc Natl Acad Sci USA 90 1977 1981
9. S Lehrer 1998 Possible relationship of the apolipoprotein E (Apo E) ε4 allele to prostate cancer Br J Cancer 78 1398
10. K Kervinen H Sodervik J Makela J Lehtola M Niemi MI Karailuoma YA Kesaniemi 1996 Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterol 110 1785 1790
11. KB Moysich JL Freudenheim JA Baker CB Ambrosone ED Bowman EF Schisterman JE Vena PG Shields 1999 ApoE4 gene linked to breast cancer BMJ 319 662
12. KB Moysich JL Freudenheim JA Baker CB Ambrosone ED Bowman EF Schisterman JE Vena PG Shields 2000 Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk Mol Carcinog 27 2 9
13. E Zunarelli JAR Nicol M Migaldi GP Trentini 2000 Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome Breast Cancer Res Treat 63 193 198
14. DM Hallman E Boerwinkle N Saha C Sandholzer HJ Menzel A Csazar G Utermann 1991 The apolipoprotein E polymorphism: A son of allele frequencies and effects in nine populations Am J Hum Genet 49 338 349
15. JE Eichner ST Dunn G Perveen DM Thompson KE Stewart BC Stroehla 2002 Apolipoprotein E polymorphism and cardiovascular disease: a human genome epidemiology review Am J Epidemiol 155 487 495
16. CM Balch AC Buzaid SJ Soong MB Atkins N Cascinelli DG Coit ID Fleming JE Gershenwald A Houghton Jr JM Kirkwood KM McMasters MF Mihm DL Morton DS Reintgen MI Ross A Sober JA Thompson JF Thompson 2003 New TNM melanoma staging system: linking biology and natural history to clinical outcomes Semin Surg Oncol 21 43 52
17. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410
18. G Chebil PO Bendahl I Idvall M Ferno 2003 Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer-clinical associations and reasons for discrepancies Acta Oncol 42 719 725
19. P Regitnig W Schippinger M Lindbauer H Samonigg SF Lax 2004 Change of HER-2/neu status in a subset of distant metastases from breast carcinomas J Pathol 203 918 926
20. JE Hixson DT Vernier 1990 Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 31 545 548
21. O Takatani T Okumoto H Kosano 1991 Genesis of breast cancer in Japanese: a possible relationship between sex hormone binding globulin (SHBG) and serum lipid components Breast Cancer Res Treat 18 Suppl 1 527 529
22. L Brinton J Lacey SS Devesa 2002 Epidemiology of Breast Cancer WL Donegan JS Spratt Cancer of the Breast 5 WB Saunders Philadelphia 111 132
23. Y Emi K Kitamura Y Shikada Y Kakeji I Takahashi S Tsutsui 2002 Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis Surgery 131 Suppl 1 S217 S221
24. DJ Slamon GM Clark SG Wong WJ Levin A Ullrich WL McGuire 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 177 182
25. TJ Key MC Pike 1988 The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer Eur J Cancer Clin Oncol 24 29 43
26. S Nilsson S Makela E Treuter M Tujague J Thomsen G Andersson E Enmark K Pettersson M Warner JA Gustafsson 2001 Mechanisms of estrogen action Physiol Rev 81 1535 1565